JAMES CONRAD EISENACH, MD
Anesthesiologist Assistant at Medical Center Blvd, Winston Salem, NC
License number
North Carolina 29912
Category
Osteopathic Medicine
Type
Pain Medicine
License number
North Carolina 29912
Category
Osteopathic Medicine
Type
Anesthesiology
Address
Address
Medical Center Blvd, Winston Salem, NC 27157
Phone
(336) 716-2255
Professional information
James Conrad Eisenach, Winston Salem NC
Specialties:
Anesthesiologist
Address:
3333 Silas Creek Pkwy, Winston Salem, NC 27103
Medical Center Blvd, Winston Salem, NC 27157
Medical Center Blvd, Winston Salem, NC 27157
Board certifications:
American Board of Anesthesiology Certification in Anesthesiology
Dr. James C Eisenach, Winston Salem NC - MD (Doctor of Medicine)
Specialties:
Anesthesiology
Address:
FORSYTH MEDICAL CENTER
3333 Silas Creek Pkwy, Winston Salem 27103
(336) 718-7080 (Phone), (336) 718-9622 (Fax)
WAKE FOREST UNIVERSITY
Medical Center Blvd, Winston Salem 27157
(336) 716-2011 (Phone)
3333 Silas Creek Pkwy, Winston Salem 27103
(336) 718-7080 (Phone), (336) 718-9622 (Fax)
WAKE FOREST UNIVERSITY
Medical Center Blvd, Winston Salem 27157
(336) 716-2011 (Phone)
Certifications:
Anesthesiology, 2001
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
FORSYTH MEDICAL CENTER
3333 Silas Creek Pkwy, Winston Salem 27103
WAKE FOREST UNIVERSITY
Medical Center Blvd, Winston Salem 27157
Wake Forest Baptist Medical Center
Medical Center Blvd, Winston Salem 27157
3333 Silas Creek Pkwy, Winston Salem 27103
WAKE FOREST UNIVERSITY
Medical Center Blvd, Winston Salem 27157
Wake Forest Baptist Medical Center
Medical Center Blvd, Winston Salem 27157
Education:
Medical School
University of California At San Francisco
Graduated: 1982
Mt Zion Hospital and Med Center
Graduated: 1983
Mayo Clin
Graduated: 1985
Bowman Gray School Med
Graduated: 1986
University of California At San Francisco
Graduated: 1982
Mt Zion Hospital and Med Center
Graduated: 1983
Mayo Clin
Graduated: 1985
Bowman Gray School Med
Graduated: 1986
Compositions And Methods For Treating Pain Using Cyclooxygenase-1 Inhibitors
US Patent:
2003018, Sep 25, 2003
Filed:
Feb 11, 2003
Appl. No.:
10/364258
Inventors:
James Eisenach - Winston-Salem NC, US
International Classification:
A61K031/485, A61K031/455, A61K031/445, A61K031/24, A61K031/192
US Classification:
514/161000, 514/282000, 514/317000, 514/537000, 514/560000, 514/355000
Abstract:
The present invention discloses a method of eliciting an analgesic effect in a subject in need thereof comprising intrathecally administering to the subject a therapeutically effective amount of a cyclooxygenase 1 inhibitor or pharmaceutically acceptable salt thereof in a preservative-free pharmaceutically acceptable carrier. The present invention further discloses pharmaceutical compositions comprising a cylcooxygenase 1 inhibitor or a pharmaceutically acceptable salt thereof and an adjuvant such as an adrenergic agonist, opioid analgesic, local anesthetic, and calcium channel blocker, and combinations thereof in a preservative-free pharmaceutically acceptable carrier. Kits comprising a composition comprising a cyclooxygenase 1 inhibitor or a pharmaceutically acceptable salt thereof in a preservative-free pharmaceutically acceptable carrier in a container suitable for delivery of the composition into an intrathecal administration device are also disclosed herein.
Method For The Treatment Of Pain, Including Chronic And Female Specific Pain
US Patent:
6248744, Jun 19, 2001
Filed:
Oct 5, 2000
Appl. No.:
9/622675
Inventors:
James C. Eisenach - Winston-Salem NC
Assignee:
Wake Forest University - Winston-Salem NC
International Classification:
A61K 31505
US Classification:
514256
Abstract:
Patients susceptible to, or suffering from chronic and/or female-specific pain are treated by administering an effective amount of a metanicotine-based compound.
Combination Therapy For The Treatment Of Pain
US Patent:
2008011, May 15, 2008
Filed:
Oct 16, 2007
Appl. No.:
11/872878
Inventors:
James Conrad Eisenach - Winston Salem NC, US
International Classification:
A61K 31/485, A61K 31/381, A61K 31/498, A61K 31/5513, A61K 31/4725, A61K 31/444, A61K 31/437, A61P 25/04
US Classification:
514220, 514443, 514282, 514249, 514309, 514334, 514292
Abstract:
The present invention provides synergistic combinations for the treatment of conditions associated with pain including acute pain, e.g., postoperative pain, chronic pain, inflammatory pain, neuropathic pain and pain associated with migraine. In particular, the present invention relates to the use of an allosteric adenosine Areceptor enhancer in conjunction with opioid analgesics or 2-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA)/kainate antagonists for alleviating pain, e.g., postoperative pain.
Combination Therapy For The Treatment Of Pain
US Patent:
2008010, May 8, 2008
Filed:
Oct 16, 2007
Appl. No.:
11/872859
Inventors:
James Eisenach - Winston Salem NC, US
International Classification:
A61K 31/498, A61K 31/381, A61P 25/00, A61K 31/485
US Classification:
514252100, 514282000, 514443000
Abstract:
The present invention provides synergistic combinations for the treatment of conditions associated with pain including acute pain, e.g., postoperative pain, chronic pain, inflammatory pain, neuropathic pain and pain associated with migraine. In particular, the present invention relates to the use of an allosteric adenosine Areceptor enhancer in conjunction with opioid analgesics or 2-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA)/kainate antagonists for alleviating pain, e.g., postoperative pain.
Combination Therapy For The Treatment Of Pain
US Patent:
2008010, May 8, 2008
Filed:
Oct 16, 2007
Appl. No.:
11/872800
Inventors:
James Eisenach - Winston Salem NC, US
International Classification:
A61K 31/551, A61K 31/381, A61K 31/34, A61K 31/44, A61K 31/4353, A61P 25/04, A61K 31/47, A61K 31/4965
US Classification:
514220000, 514443000, 514282000, 514468000, 514255010, 514307000, 514334000, 514292000
Abstract:
The present invention provides synergistic combinations for the treatment of conditions associated with pain including acute pain, e.g., postoperative pain, chronic pain, inflammatory pain, neuropathic pain and pain associated with migraine. In particular, the present invention relates to the use of an allosteric adenosine Areceptor enhancer in conjunction with opioid analgesics or 2-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA)/kainate antagonists for alleviating pain, e.g., postoperative pain.
Methods And Compositions For Decreasing Chronic Pain
US Patent:
2013022, Aug 29, 2013
Filed:
Apr 5, 2011
Appl. No.:
13/637977
Inventors:
Alan Horsager - Los Angeles CA, US
Kenneth Greenberg - Oakland CA, US
Benjamin C. Matteo - San Francisco CA, US
Edward S. Boyden - Chestnut MA, US
Douglas G. Ririe - Winston-Salem NC, US
James C. Eisenach - Winston-Salem NC, US
Christian Wentz - Cambridge MA, US
Kenneth Greenberg - Oakland CA, US
Benjamin C. Matteo - San Francisco CA, US
Edward S. Boyden - Chestnut MA, US
Douglas G. Ririe - Winston-Salem NC, US
James C. Eisenach - Winston-Salem NC, US
Christian Wentz - Cambridge MA, US
International Classification:
A61K 41/00, A61N 5/06
US Classification:
514 44 R, 536 231, 536 237, 4352351, 435325, 4353201, 435455, 604 20
Abstract:
The present invention provides compositions and methods for the selective silencing of neurons in pain pathway by using a combination of inhibitory light-sensitive protein gene transfer and wavelength specific illumination.